Inflammatory bowel disease and melanoma

Patients with inflammatory bowel disease (IBD) have an increased risk of melanoma and non-melanoma skin cancer (NMSC), according to US researchers

The study analysed the retrospective cohort and nested case-control studies to quantify the risk and how medications such as biologics affect this risk. Patients with Crohn's disease had a higher incidence of both melanoma and NMSC. Patients with IBD who were on biologics had a higher risk of melanoma, while those taking thiopurines had an increased risk of NMSC. The authors state that the increased risk is due to the immunosuppression of patients with IBD and recommend skin cancer surveillance and counselling of all patients with IBD.
Long MD, Martin C, Pipkin CA et al. Gastroenterology 2012

Read these next

Retinol and melanoma risk

Intake of high-dose (>1,200 microgram per day) retinol...

The increase in non-melanoma skin cancer

The increase in non-melanoma skin cancer

Sun-seeking behaviour is thought to be the main cause...

Computer-aided skin lesion analysis in melanoma

Computer-aided digital skin lesion analysis can improve...

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases